The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment
NCT04358224 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2023-02-08
Summary
The utility of functionally relevant signature genes in assessing the clinical outcomes of dupilumab treatment in the adult onset atopic dermatitis
Conditions
Interventions
- BIOLOGICAL
-
Dupilumab Prefilled Syringe
open-label
Sponsors & Collaborators
-
Jonathan A. Bernstein, MD
lead OTHER
Principal Investigators
-
Jonathan Bernstein · Bernstein Clinial Research Center
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 19 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-01
- Primary Completion
- 2022-11-18
- Completion
- 2022-11-18
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
ADRN Barrier/Immunoprofiling Exploratory Pilot Study
NCT02115399 ·Status: COMPLETED
-
Characterization of Chronic Hand Eczema
NCT05026554 ·Status: RECRUITING
-
Methotrexat to Hand Eczema in the BIOSKIN Cohort
NCT07338305 ·Status: ACTIVE_NOT_RECRUITING
-
Autologous Serum Skin Testing in Patients With Atopic Dermatitis Autologous Serum Skin Testing in Patients With Atopic Dermatitis
NCT01238263 ·Status: COMPLETED
-
A Study to Evaluate Microneedle-based Collection of Dermal Interstitial Skin Fluid in Healthy Participants and Atopic Dermatitis Participants
NCT06934980 ·Status: COMPLETED
-
Etanercept for the Treatment of Chronic Urticaria
NCT01030120 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Registry for the Atopic Dermatitis Research Network
NCT01494142 ·Status: COMPLETED
-
Characterization of the Molecular Mechanisms Involved in Delayed-Type Hypersensitivity Reactions to House Dust Mite, Diphencyprone, Nickel, and Tuberculin Purified Protein Derivative in Healthy Volunteers
NCT03625219 ·Status: COMPLETED ·Phase: NA
-
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
NCT05535738 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy of Dexpanthenol in Thermic Erythema
NCT00839462 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients
NCT04369846 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparing DCP and DAP for Pemphigus Vulgaris
NCT06846255 ·Status: COMPLETED ·Phase: PHASE4
-
Natural History of Severe Allergic Inflammation and Reactions
NCT01164241 ·Status: COMPLETED
-
Immune Reactions in Contact Dermatitis Affected Skin
NCT01546298 ·Status: COMPLETED
-
Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
NCT03389308 ·Status: COMPLETED ·Phase: PHASE2
-
Cooling Pillow for Atopic Dermatitis
NCT01132651 ·Status: COMPLETED ·Phase: NA
-
Pilot Study on the Use of Acitretin for the Treatment of Severe Chronic Hand Dermatitis
NCT01545284 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety Study of Gene-modified Autologous Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa
NCT02493816 ·Status: COMPLETED ·Phase: PHASE1
-
Scratching Validation Study
NCT05137093 ·Status: COMPLETED
-
A Prospective Study to Investigate Contact Sensitization Using Classic and Machine Learning Techniques
NCT05991674 ·Status: UNKNOWN
-
A Study of BRT-FC-83C for the Treatment of Atopic Dermatitis
NCT00883311 ·Status: COMPLETED ·Phase: PHASE2
-
Common Allergens in Skin Tests for Adult Atopic Dermatitis
NCT00173498 ·Status: UNKNOWN
-
Comparative Study of the Efficacy of SARNA Sensitive Lotion for Treatment of Uremic Itch in Adult Hemodialysis Patients
NCT00693654 ·Status: COMPLETED ·Phase: PHASE4
-
Skin Pathology Assessment With Optical Technologies
NCT04295824 ·Status: COMPLETED
-
Long-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj.
NCT03458624 ·Status: UNKNOWN